We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+18.02%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$40.8M
(+19%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
25.74%
Holding
236
New
24
Increased
57
Reduced
82
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$8.05M |
| 2 |
IBM
IBM
|
+$3.95M |
| 3 |
Vanguard Health Care ETF
VHT
|
+$3.42M |
| 4 |
Vanguard Consumer Discretionary ETF
VCR
|
+$3.18M |
| 5 |
Vanguard Communication Services ETF
VOX
|
+$3.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$4.09M |
| 2 |
Gentex
GNTX
|
+$1.95M |
| 3 |
SiriusXM
SIRI
|
+$1.89M |
| 4 |
VeriSign
VRSN
|
+$1.63M |
| 5 |
Novartis
NVS
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.16% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 9.69% |
| 4 | Consumer Discretionary | 8.9% |
| 5 | Communication Services | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Edwards Lifesciences
EW
$49.4B
| $2.52M | 0.98% |
39,564
-2,046
| -5% | -$117K |
|
27
Texas Pacific Land
TPL
$28.7B
| $2.51M | 0.98% |
29,250
+2,700
| +10% | +$211K |
|
28
Warner Bros
WBD
$67.4B
| $2.4M | 0.94% |
88,691
-14,751
| -14% | -$410K |
|
29
Avery Dennison
AVY
$12.3B
| $2.39M | 0.93% |
21,160
-1,037
| -5% | -$107K |
|
|
FITB
30
Fifth Third Bancorp
FITB
$52.6B
| $2.34M | 0.91% |
92,740
-1,530
| -2% | -$40.8K |
|
31
Lowe's Companies
LOW
$117B
| $2.3M | 0.9% |
20,997
-67
| -0.3% | -$6.69K |
|
|
LLL
32
DELISTED
L3 Technologies, Inc.
LLL
| $2.24M | 0.87% |
10,834
+883
| +9% | +$175K |
|
|
MNTV
33
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.21M | 0.86% |
+121,580
| New | +$1.71M |
|
34
US Physical Therapy
USPH
$1.12B
| $2.2M | 0.86% |
20,932
+3,144
| +18% | +$338K |
|
35
CVR Energy
CVI
$3.53B
| $2.17M | 0.85% |
52,653
+3,510
| +7% | +$140K |
|
36
CMS Energy
CMS
$22.8B
| $2.13M | 0.83% |
38,349
+6,728
| +21% | +$355K |
|
37
Palo Alto Networks
PANW
$292B
| $2.07M | 0.81% |
+51,072
| New | +$1.89M |
|
38
iShares Core S&P 500 ETF
IVV
$881B
| $2.06M | 0.8% |
7,240
| – | – |
|
39
Digital Realty Trust
DLR
$64.3B
| $2.01M | 0.78% |
16,903
+1,086
| +7% | +$121K |
|
40
Sherwin-Williams
SHW
$81.7B
| $1.98M | 0.77% |
13,758
-1,575
| -10% | -$219K |
|
41
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $1.9M | 0.74% |
6,708
+4,207
| +168% | +$1.14M |
|
42
National Storage Affiliates Trust
NSA
$3.45B
| $1.88M | 0.74% |
66,065
+6,351
| +11% | +$176K |
|
43
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $1.84M | 0.72% |
+20,324
| New | +$1.73M |
|
44
Berkshire Hathaway Class A
BRK.A
$1.06T
| $1.81M | 0.71% |
+6
| New | +$1.82M |
|
45
Altria Group
MO
$124B
| $1.76M | 0.69% |
30,675
+200
| +0.7% | +$10.2K |
|
46
Graco
GGG
$12.4B
| $1.75M | 0.68% |
35,332
-1,488
| -4% | -$67.4K |
|
47
Amgen
AMGN
$198B
| $1.72M | 0.67% |
9,073
-6,702
| -42% | -$1.28M |
|
48
Graphic Packaging
GPK
$3.2B
| $1.7M | 0.66% |
134,804
+81,754
| +154% | +$993K |
|
49
Meta Platforms (Facebook)
META
$1.64T
| $1.7M | 0.66% |
10,200
-900
| -8% | -$143K |
|
50
Realty Income
O
$61.3B
| $1.69M | 0.66% |
23,740
+619
| +3% | +$41K |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Grace Capital held 236 positions worth $256M, up 19% from $215M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Grace Capital deployed $11.8M of net new capital in Q1 2019, opening 24 new positions and adding to 57 existing holdings. Its largest new stake was IBM: 30,988 shares worth $4.18M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was MyoKardia, Inc. Common Stock, an estimated $4.09M trimmed.
- Grace Capital's largest Q1 2019 buy was IBM: 30,988 shares worth $4.18M.
- Grace Capital added most to Global Blood Therapeutics, Inc. in Q1 2019, an estimated $8.05M increase.
- Grace Capital's biggest Q1 2019 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $4.09M.
- Grace Capital fully exited Gentex in Q1 2019, selling an estimated $1.95M.
- Grace Capital's ten largest holdings make up 26% of its $256M portfolio in Q1 2019.
- Grace Capital opened 24 new positions and closed 36 in Q1 2019.
- Grace Capital's portfolio value rose 19% quarter-over-quarter to $256M.
Based on Grace Capital's 13F filing for Q1 2019, filed 15 May 2019.